Drugs / Umbilical mesenchymal stem cell
Umbilical mesenchymal stem cell
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01374854 | Jan 2009 → Dec 2010 | type 1 diabetes mellitus | Fuzhou General Hospital | Unknown | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Umbilical mesenchymal stem cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01374854 ↗ |
| Known as | UC-MSC | “Umbilical mesenchymal stem cell (UC-MSCs) infusion” NCT01374854 ↗ |
| Known as | UC-MSCs | “Umbilical mesenchymal stem cell (UC-MSCs) infusion” NCT01374854 ↗ |
| Action | Restore | “infusion of USC-MSCs may provide multiple signals for beta-cell regeneration” NCT01374854 ↗ |
| Modality | Cell therapy | “umbilical mesenchymal stem cells (UC-MSCs) infusion” NCT01374854 ↗ |
| Route | Other | “1×10\^6/kg UC-MSCs is infused through pancreatic artery” NCT01374854 ↗ |